ConductScience.org, home

Paper20186583

The impact of viability assessment using myocardial perfusion imaging on patient management and outcome.

Hage FG and 7 others. J Nucl Cardiol, 2010. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. Papers, record 20186583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20186583

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The impact of viability assessment using myocardial perfusion imaging on patient management and outcome.
PubMed
Journal
J Nucl Cardiol
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2024-01-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hage FGFadi G
2Venkataraman RRajesh
3Aljaroudi WWael
4Bravo PEPaco E
5McLarry JJoel
6Faulkner MMichael
7Heo JJaekyeong
8Iskandrian AEAmi E

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CardiomyopathiesMajor topic
Myocardial IschemiaMajor topic
Myocardial Perfusion ImagingMajor topic
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography
Coronary Artery Bypass
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Proportional Hazards Models
Radioisotopes
Stroke Volume
Thallium Radioisotopes

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119761983Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.JACC Cardiovasc Imaging2009https://conductscience.org/library/papers/19761983PubMed
29386070The risks of reoperative coronary artery bypass in chronic ischemic cardiomyopathy: results of the CABG Patch Trial.Circulation1997https://conductscience.org/library/papers/9386070PubMed
33812178Differentiation of viable and nonviable myocardium after acute reperfusion using serial thallium-201 imaging.Am Heart J1987https://conductscience.org/library/papers/3812178PubMed
412853194Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.Lancet2003https://conductscience.org/library/papers/12853194PubMed
57357723Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise.Circulation1980https://conductscience.org/library/papers/7357723PubMed
612106836Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).Am J Cardiol2002https://conductscience.org/library/papers/12106836PubMed
717574986Assessment of myocardial viability in patients with heart failure.J Nucl Med2007https://conductscience.org/library/papers/17574986PubMed
819679284Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.JACC Cardiovasc Imaging2009https://conductscience.org/library/papers/19679284PubMed
912409541Long-term trends in the incidence of and survival with heart failure.N Engl J Med2002https://conductscience.org/library/papers/12409541PubMed
106846171Relation of immediate and delayed thallium-201 distribution to localization of iodine-125 antimyosin antibody in acute experimental myocardial infarction.Am J Cardiol1983https://conductscience.org/library/papers/6846171PubMed
116169270Myocardial salvage by intracoronary thrombolysis in evolving acute myocardial infarction: evaluation using intracoronary injection of thallium-201.Am Heart J1981https://conductscience.org/library/papers/6169270PubMed
127655730Is reoperative coronary artery bypass grafting in patients with poor left ventricular ejection fractions < or = 25% worthwhile?Coron Artery Dis1995https://conductscience.org/library/papers/7655730PubMed
1311923039Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.J Am Coll Cardiol2002https://conductscience.org/library/papers/11923039PubMed
147717274Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy.Am J Cardiol1995https://conductscience.org/library/papers/7717274PubMed
1511092664Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy.J Am Coll Cardiol2000https://conductscience.org/library/papers/11092664PubMed
162331770Thallium 201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction.Circulation1990https://conductscience.org/library/papers/2331770PubMed
1718022099Myocardial perfusion and function: single photon emission computed tomography.J Nucl Cardiol2007https://conductscience.org/library/papers/18022099PubMed
1814697459Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction.Am J Cardiol2004https://conductscience.org/library/papers/14697459PubMed
197261290Myocardial thallium-201 kinetics in normal and ischemic myocardium.Circulation1981https://conductscience.org/library/papers/7261290PubMed
20872309The extraction of thallium-201 by the myocardium.Circulation1977https://conductscience.org/library/papers/872309PubMed

See all 34 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
39726883Investigation Myocardial Perfusion Scan Parameters and Walls Motion in Patients undergoing Cardiac Surgery.J Biomed Phys Eng2024https://conductscience.org/library/papers/39726883PubMed
35864433Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.J Nucl Cardiol2023https://conductscience.org/library/papers/35864433PubMed
33748938What is this image? 2021: Image 5 result : Progression of myocardial ischemia to scar on serial 99mTc-sestamibi myocardial perfusion imaging.J Nucl Cardiol2021https://conductscience.org/library/papers/33748938PubMed
31646471Myocardial infarction assessment by surface electrocardiography.J Nucl Cardiol2021https://conductscience.org/library/papers/31646471PubMed
24858622The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease.J Nucl Cardiol2014https://conductscience.org/library/papers/24858622PubMed
22259011Towards personalized myocardial viability testing: personal reflections.J Nucl Cardiol2012https://conductscience.org/library/papers/22259011PubMed
21785922A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.J Nucl Cardiol2011https://conductscience.org/library/papers/21785922PubMed
21463153Myocardial viability and survival in ischemic left ventricular dysfunction.N Engl J Med2011https://conductscience.org/library/papers/21463153PubMed
20848256Safety of regadenoson in patients with end-stage liver disease.J Nucl Cardiol2011https://conductscience.org/library/papers/20848256PubMed
20658272Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease.J Nucl Cardiol2010https://conductscience.org/library/papers/20658272PubMed
20617468The case for cardiac magnetic resonance and positron emission tomography multimodality imaging of myocardial viability.J Nucl Cardiol2010https://conductscience.org/library/papers/20617468PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20186583

GET https://conductscience.org/api/papers/v1/20186583/references?page=2